(Reuters) -India’s Mankind Pharma reported a fourth straight quarter of profit fall on Thursday, as the government’s sweeping cuts on its goods and services taxes caused supply chain disruptions, weighing on sales volume.

The company, which makes ‘Manforce’ condoms and ‘Gas-O-Fast’ antacid tablets, said consolidated net profit fell nearly 22% to 5.12 billion rupees in the second quarter ended September 30.

Revenue rose 20.8% to 36.97 billion rupees.

KEY CONTEXT:

Mankind’s chronic illness drugs segment continued to do well, with its domestic market share rising 1.9%, led by demand for its anti-diabetic and cardiovascular medication.

The firm and its peer Torrent Pharma derive most of their sales from drugs that treat long-term conditions such as diabetes and hypertension.

However, sal

See Full Page